← All patents

US9846160B2

Ganglioside GD2 as a marker and target on cancer stem cells

University of Texas System

Abstract

Methods for determining the presence of cancer stem cells by detecting GD2 expression. Also provided are methods for reducing proliferation of cancer stem cells by contacting the cells with a GD2 targeting agent, such as an anti-GD2 antibody or a GD3 synthase inhibitor. GD3 synthase inhibitor …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas Systems
Inventor
Venkata Battula
Priority date
February 27, 2012
Filing date
February 27, 2013
Grant date
December 19, 2017
Publication date
December 19, 2017
Language
en
Metadata fetched
August 29, 2026 00:24